Endothelial dysfunction in vascular complications of diabetes: a comprehensive review of mechanisms and implications
Open accessThe DOI matches its Crossref record; 224 of the 224 references it cites were found in a registry or an index.
Abstract
Diabetic vascular complications are prevalent and severe among diabetic patients, profoundly affecting both their quality of life and long-term prospects. These complications can be classified into macrovascular and microvascular complications. Under the impact of risk factors such as elevated blood glucose, blood pressure, and cholesterol lipids, the vascular endothelium undergoes endothelial dysfunction, characterized by increased inflammation and oxidative stress, decreased NO biosynthesis, endothelial-mesenchymal transition, senescence, and even cell death. These processes will ultimately lead to macrovascular and microvascular diseases, with macrovascular diseases mainly characterized by atherosclerosis (AS) and microvascular diseases mainly characterized by thickening of the basement membrane. It further indicates a primary contributor to the elevated morbidity and mortality observed in individuals with diabetes. In this review, we will delve into the intricate mechanisms that drive endothelial dysfunction during diabetes progression and its associated vascular complications. Furthermore, we will outline various pharmacotherapies targeting diabetic endothelial dysfunction in the hope of accelerating effective therapeutic drug discovery for early control of diabetes and its vascular complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–224 of 224
Villota, S. D., Toledo‐Rodriguez, M., & Leach, L. (2020) · Diabetologia · doi:10.1007/s00125-020-05290-6 · Cited by 28
Mitochondrial Fragmentation in a High Homocysteine Environment in Diabetic Retinopathy
Kowluru, R. A., & Mohammad, G. (2022) · Antioxidants · doi:10.3390/antiox11020365 · Cited by 27
McCoy, M. G., Jamaiyar, A., Sausen, G., Cheng, H. S., Pérez‐Cremades, D., Zhuang, R., Chen, J., Goodney, P. P., Creager, M. A., Sabatine, M. S., et al. (2022) · Angiogenesis · doi:10.1007/s10456-022-09856-3 · Cited by 27
El‐Khalik, S. R. A., Hafez, Y. M., & Elkholy, R. A. (2020) · Microvascular Research · doi:10.1016/j.mvr.2020.103987 · Cited by 26
GPR56 Promotes Diabetic Kidney Disease Through eNOS Regulation in Glomerular Endothelial Cells
Wu, J., Wang, Z., Cai, M., Wang, X., Lo, B., Li, Q., He, C., Lee, K., & Fu, J. (2023) · Diabetes · doi:10.2337/db23-0124 · Cited by 26
BH4 Increases nNOS Activity and Preserves Left Ventricular Function in Diabetes
Carnicer, R., Duglan, D., Žiberna, K., Récalde, A., Reilly, S. N., Simon, J. N., Mafrici, S. F., Arya, R., Roselló‐Lletí, E., Chuaiphichai, S., et al. (2021) · Circulation Research · doi:10.1161/circresaha.120.316656 · Cited by 23
Cuore, A. D., Pipitone, R. M., Casuccio, A., Mazzola, M. M., Puleo, M. G., Pacinella, G., Riolo, R., Maida, C. D., Chiara, T. D., Raimondo, D. D., et al. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01880-x · Cited by 23
Zhu, W., Li, S., Lin, L.-Q., Yan, H. M., Fu, T., & Zhu, J. (2008) · Cellular Immunology · doi:10.1016/j.cellimm.2008.08.001 · Cited by 21
Liraglutide Accelerates Ischemia‐Induced Angiogenesis in a Murine Diabetic Model
Zhu, Y., Li, Y., Ma, Y., Zhang, X., Du, X., Gao, J., Ding, N., Wang, L., Chen, N., Luo, M., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.026586 · Cited by 21
Wu, C., Hu, S., Wang, N., & Tian, J. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6501 · Cited by 20
Vascular protection of DPP-4 inhibitors in retinal endothelial cells in in vitro culture
Li, H., Zhang, J., Li, L., & Xu, L. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.10.040 · Cited by 20
Bapir, M., Untracht, G. R., Cooke, D. D., McVey, J. H., Skene, S. S., Campagnolo, P., Whyte, M., Δικαίος, Ν., Rodriguez‐Mateos, A., Sampson, D. D., et al. (2022) · Food & Function · doi:10.1039/d2fo02017c · Cited by 20
The SGLT2 inhibitor empagliflozin attenuates atherosclerosis progression by inducing autophagy
Xu, H., Fu, J., Tu, Q., Shuai, Q. Y., Chen, Y., Wu, F., & Cao, Z. (2023) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-023-00974-0 · Cited by 20
Mikhail, M., Vachon, P. H., D’Orléans-Juste, P., Jacques, D., & Bkaily, G. (2017) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2017-0412 · Cited by 19
Day, S. M., Yang, W., Ewin, S. E., Zhou, X., & Ma, T. (2017) · Hippocampus · doi:10.1002/hipo.22795 · Cited by 19
Linagliptin reduces effects of ET-1 and TLR2-mediated cerebrovascular hyperreactivity in diabetes
Hardigan, T., Abdul, Y., & Ergul, A. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.02.067 · Cited by 17
Li, X., Kerindongo, R. P., Preckel, B., Kalina, J.-O., Hollmann, M. W., Zuurbier, C. J., & Weber, N. C. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114228 · Cited by 17
Seo, S., Kim, M. K., Kim, R.-I., Yeo, Y., Kim, K. L., & Suh, W. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00512-8 · Cited by 16
Shati, A. A., Maarouf, A., Dawood, A. F., Bayoumy, N. M. K., Alqahtani, Y. A., Eid, R. A., Alqahtani, S. M., Ellatif, M. E. A., Al‐Ani, B., & Albawardi, A. S. (2023) · Biomedicines · doi:10.3390/biomedicines11020361 · Cited by 16
Vanchin, B., Sol, M., Gjaltema, R. A. F., Brinker, M. G. L., Kiers, B., Pereira, A. C., Harmsen, M. C., Moonen, J.-R. A. J., & Krenning, G. (2021) · Scientific Reports · doi:10.1038/s41598-021-97127-4 · Cited by 15
Rosenson, R., Chen, Q., Najera, S. D., Lee, M. L., & Cho, D. (2018) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-018-6815-9 · Cited by 13
Lotan, R., Ganmore, I., Livny, A., Shelly, S., Zacharia, M., Uribarri, J., Beisswenger, P. J., Cai, W., Beeri, M. S., & Troen, A. M. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.614149 · Cited by 8
Shen, C., Li, K., Wu, C.-H., Lu, C., Kuo, Y., Hsieh, S., & Yu, C. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109655 · Cited by 8
Khalse, M., & Ganapathi, B. (2020) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_568_19 · Cited by 2
Cited by
Endothelial Dysfunction as the Common Pathway Linking Obesity, Hypertension and Atherosclerosis
Młynarska, E., Bojdo, K., Frankenstein, H., Krawiranda, K., Kustosik, N., Lisińska, W., Rysz, J., & Franczyk, B. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262010096 · Cited by 87
“This imbalance contributes to reduced NO synthesis and endothe-Int lial dysfunction [69].”
Metadata
- Authors
- Yang, D.-R., Wang, M.-Y., Zhang, C.-L., & Wang, Y.
- Venue
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Published
- 2024-04-05
- Volume
- 15
- Pages
- 1359255-1359255
- ISSN
- 1664-2392 (ISSN-L)
- OpenAlex
- W4393987103
- Cited by
- 280
- References
- 224
- FWCI
- 66.22
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.